PAI-1, a target gene of miR-143, regulates invasion and metastasis by upregulating MMP-13 expression of human osteosarcoma

Cancer Med. 2016 May;5(5):892-902. doi: 10.1002/cam4.651. Epub 2016 Jan 28.

Abstract

Despite recent improvements in the therapy for osteosarcoma, 30-40% of osteosarcoma patients die of this disease, mainly due to its lung metastasis. We have previously reported that intravenous injection of miR-143 significantly suppresses lung metastasis of human osteosarcoma cells (143B) in a mouse model. In this study, we examined the biological role and mechanism of miR-143 in the metastasis of human osteosarcoma cells. We identified plasminogen activator inhibitor-1 (PAI-1) as a direct target gene of miR-143. To determine the role of PAI-1 in human osteosarcoma cells, siRNA was transfected into 143B cells for knockdown of PAI-1 expression. An in vitro study showed that downregulation of PAI-1 suppressed cell invasion activity, but not proliferation. Moreover, injection of PAI-1 siRNA into a primary lesion in the osteosarcoma mouse model inhibited lung metastasis compared to control siRNA-injected mice, without influencing the proliferative activity of the tumor cells. Subsequent examination using 143B cells revealed that knockdown of PAI-1 expression resulted in downregulation of the expression and secretion of matrix metalloproteinase-13 (MMP-13), which is also a target gene of miR-143 and a proteolytic enzyme that regulates tumor-induced osteolysis. Immunohistochemical analysis using clinical samples showed that higher miR-143 expressing cases showed poor expression of PAI-1 in the primary tumor cells. All such cases belonged to the lung metastasis-negative group. Moreover, the frequency of lung metastasis-positive cases was significantly higher in PAI-1 and MMP-13 double-positive cases than in PAI-1 or MMP-13 single-positive or double-negative cases (P < 0.05). These results indicated that PAI-1, a target gene of miR-143, regulates invasion and lung metastasis via enhancement of MMP-13 expression and secretion in human osteosarcoma cells, suggesting that these molecules could be potential therapeutic target genes for preventing lung metastasis in osteosarcoma patients.

Keywords: MMP-13; Osteosarcoma; PAI-1; metastasis; miR-143.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Neoplasms / genetics*
  • Bone Neoplasms / pathology
  • Cell Proliferation / genetics
  • Down-Regulation / genetics
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques / methods
  • Heterografts
  • Humans
  • Lung Neoplasms / prevention & control
  • Lung Neoplasms / secondary
  • Male
  • Matrix Metalloproteinase 13 / biosynthesis*
  • Mice, Nude
  • MicroRNAs / genetics*
  • MicroRNAs / physiology
  • Neoplasm Invasiveness / genetics
  • Neoplasm Proteins / genetics
  • Neoplasm Transplantation
  • Osteosarcoma / genetics*
  • Osteosarcoma / pathology
  • Osteosarcoma / secondary
  • Plasminogen Activator Inhibitor 1 / genetics*
  • RNA, Small Interfering / genetics
  • Transfection
  • Tumor Cells, Cultured
  • Up-Regulation / genetics

Substances

  • MIRN143 microRNA, human
  • MicroRNAs
  • Neoplasm Proteins
  • Plasminogen Activator Inhibitor 1
  • RNA, Small Interfering
  • SERPINE1 protein, human
  • MMP13 protein, human
  • Matrix Metalloproteinase 13